Latest Commercial Modelling News

FlexiRoam has onboarded one of Australia’s four major banks to offer complimentary global data roaming on premium rewards Mastercard cards. The live program is expected to generate about USD 140,000 a year under management’s current planning case, although there is no minimum revenue commitment.

Pure One Corporation Limited (ASX:P1E) reported FY26 net profit after tax of A$5.070 million, alongside A$7.191 million in cash and term deposits. The company is positioning battery-swappable heavy vehicles and electric vans as its growth engine, while retaining sizeable interests in gas and clean-energy ventures.

Neuren says its partner Acadia has received a US Notice of Allowance for a trofinetide patent that could protect weight-banded dosing through 28 March 2041. The patent has not yet formally issued, but the allowance could extend US protection by almost five years beyond the existing method-of-use patent.

Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.

Lithium Universe has secured selection for a proposed four-year Industry PhD project with Macquarie University and CSIRO to develop microwave-assisted recycling of end-of-life solar panels. The collaboration could strengthen the company’s technology pathway, but its grant, agreement and commercial outcomes remain unconfirmed.

FBR Limited secures A$4 million through a discounted placement and share purchase plan to fund development and deployment of its DST-enabled robotics products, including Mantis welding and Hadrian bricklaying robots.

CONNEQT Health has inked a marketing deal with US longevity platform Blueprint to boost consumer sales of its FDA-cleared Pulse arterial health monitor, targeting health-conscious Americans focused on preventative care.

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.

OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.

Spacetalk Ltd reported a 17% revenue decline in FY26 amid a strategic reset, but mobile revenue grew 16% as the company pivots to a software-led family safety platform supported by new telco partnerships.

WiseTech Global posted a record $1.4 billion in revenue for FY26, driven by the e2open acquisition and AI-led efficiencies, while underlying net profit rose 29%. The company outlines a confident FY27 growth outlook amid ongoing integration and innovation.

Tabcorp Holdings posted modest revenue growth and a sharp rise in net profit for FY26, while unveiling a major acquisition to accelerate its wagering technology transformation.